scispace - formally typeset
K

Kurt Heininger

Researcher at University of Düsseldorf

Publications -  59
Citations -  2863

Kurt Heininger is an academic researcher from University of Düsseldorf. The author has contributed to research in topics: T cell & Myasthenia gravis. The author has an hindex of 30, co-authored 59 publications receiving 2813 citations. Previous affiliations of Kurt Heininger include Ludwig Maximilian University of Munich.

Papers
More filters
Journal ArticleDOI

Myasthenia gravis: Long‐term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity

TL;DR: Patients with myasthenia gravis were examined prospectively by measuring serial titers of antibodies against human acetylcholine receptor, and these were correlated with a quantitative clinical score, suggesting that the autoimmune B-cell clones that formed these classes of antibodies may have been activated asynchronously.
Journal ArticleDOI

Autoimmune human T lymphocytes specific for acetylcholine receptor

TL;DR: The isolation of autoreactive T cells from six patients with myasthenia gravis is reported on, finding that AChR-induced proliferation could be inhibited with two monoclonal antibodies against monomorphic DR determinants and also with DR3-specific alloantiserum.
Journal ArticleDOI

The role of macrophages and eicosanoids in the pathogenesis of experimental allergic neuritis. Serial clinical, electrophysiological, biochemical and morphological observations.

TL;DR: It is inferred that macrophage-derived proinflammatory arachidonic acid metabolites significantly contribute to functional and tissue damage in EAN.
Journal ArticleDOI

T cell activation in Guillain‐Barré syndrome and in MS: Elevated serum levels of soluble IL‐2 receptors

TL;DR: In this article, the authors determined serum concentrations of soluble interleukin-2 receptors (sIL-2 R) in 50 patients with Guillain-Barre syndrome, 24 with CIDP, and 54 with MS.
Journal ArticleDOI

The role of interferon-gamma in the pathogenesis of experimental autoimmune disease of the peripheral nervous system.

TL;DR: Observations establish a pivotal role of the cytokine interferon‐gamma in the pathogenesis of experimental autoimmune disease of the peripheral nervous system.